From a tax perspective a lot of the detail is not announced in the budget itself but buried in the supporting documents that are subsequently released by HM Treasury and HMRC.
As ever, the devil is in the detail, and now the dust has settled on this year’s budget there are some clearer indications as to how it will impact upon OMBs and as to the general direction of travel.
However, rather than try and summarise all the relevant measures (which have been amply covered by updates circulated by various firms of professional advisers) we want to focus on the ramifications of a couple of the measures on succession planning for OMBs.
Capital Gains Tax (CGT)
In recent years speculation has always been rife prior to the budget about potential increases in capital gains tax (including a possible alignment with income tax rates). Whilst no direct increases in CGT rates were announced this year there were some indirect measures that do have the effect of increasing tax on the sale of businesses, namely the reduction of the lifetime limit for Business Asset Disposal Relief (BADR), formerly known as Entrepreneurs’ Relief, from £1m to £500,000. With BADR now resulting in a tax rate of 18% as opposed to 24% this means the maximum relief (per individual/trust) will be reduced from £60K to £30k from 6 April 2027.
The tax system has always been used as a lever to encourage investment, growth and innovation through a range of incentives for both businesses (such as R&D reliefs and enhanced capital allowances) and individuals. In the latter case there has long been a reduced rate of capital gains tax for the disposal of business assets via taper relief and then Entrepreneurs’ Relief which was first introduced in 2008 and provided for a reduced rate of 10% CGT on qualifying lifetime gains up to £1m. This limit was later increased to £10m between 2011 and 2020 providing a tax saving of up to £1m.
Since 2020, when Entrepreneurs’ Relief was rebadged as BADR, the benefit of BADR has been gradually eroded, particularly with the 10% rate being increased to 14% in 2025 and 18% in 2026. This, coupled with the halving of the lifetime limit announced in this year’s budget, significantly reduces the value of the benefit (and is an effective tax increase by the back door). It also appears to lay the ground for the potential scrapping of the relief altogether in the near future.
For those smaller businesses who are already in the process of, or looking to sell, a sale pre 6 April 2027 (before the lifetime limit) is halved can however still provide a material benefit.
For example, for a company jointly owned by two individuals that is to be sold for a gain of £2m, a sale pre 6 April 2027 will provide a total tax saving of £120K versus a tax saving of £60k post 6 April 2027.
| Pre 6 April 2027 | Post 6 April 2027 | ||
|---|---|---|---|---|
| Owner 1 (50%) | Owner 2 (50%) | Owner 1 (50%) | Owner 2 (50%) |
Gain | £1,000,000 | £1,000,000 | £1,000,000 | £1,000,000 |
Tax | £180,000 | £180,000 | £210,000 | £210,000 |
Net | £820,000 | £820,000 | £790,000 | £790,000 |
This “saving” would likely cover all (or the substantial majority of) the relevant costs of the sale.
The sale of a company or business often takes longer than anticipated so for those in the process of, or looking to, sell it is important to move quickly and get the process started as soon as possible to try and ensure everything can be completed pre 6 April 2027. For those in regulated sectors, where regulatory consents or approvals may be required, it is important to remember that those approvals or consents must also be in place pre 6 April 2027 (as for tax purposes where the contract is conditional the date of sale is the date the condition is satisfied not the date the deal is signed).
But what about the newly announced Founders’ Relief?
Founders’ Relief
Although stated to be a world-leading tax offer for founders offering a reduced 10% CGT rate for founders on up to £10 million of lifetime gains from 6 April 2027, the reality is that the conditions required to qualify for the relief (as summarised below) mean that, by the governments own predictions, only around 400 businesses and 600 individuals a year are likely to qualify.
The proposed conditions make it clear that the relief is effectively targeted at high growth companies, primarily in the tech sector, and is unlikely to benefit the vast majority of family owned businesses whose tax bill on exit will instead be raised by the BADR changes noted above.
The current proposals are that in order to qualify for Founders’ Relief:
the shareholder (founder) will need to be UK resident and have held at least 25% of the ordinary share capital (voting, capital and dividend rights) at the point the relevant trade commences and to hold the shares for at least 5 years before sale; and
the company must:
be a UK tax trading company, or the holding company of a trading group, without substantial non-trading activities or excluded trading activities (essentially the same rules that apply to EIS investments) and have £10m turnover at time of sale and at least 15 full time employees (not including directors); and
meet at least 2 of the following 3 criteria
Turnover test: Annual average compound growth in turnover of 25% across three consecutive accounting periods within the ten years before disposal, with turnover of at least £10 million in the accounting period before the first of these three periods.
Headcount test: Annual average compound growth of at least 25% in qualifying full-time equivalent employees across three consecutive accounting periods within the ten years before disposal, with at least 15 full-time employees in the accounting period before the first of these three periods.
Innovation test: the company must (1) have incurred qualifying expenditure of £1.5 million or more on research and development (R&D) for which it met all of the conditions to make an R&D tax relief claim and (2) have claimed R&D tax reliefs for that expenditure for an accounting period or periods ending within the three years before disposal.
For those limited number of shareholders and companies who may qualify (bearing in mind also that the precise requirements may change — albeit there are more likely to be relaxations than anything else) and who are currently in the process of selling their shares they may wish to look at deferring the sale until post 5 April 2027.